Decoding Risk, Severity and Complications of Dengue in 10 Questions
Thursday, December 18th 2025 - 3:30 PM (IST)
5 days to go
99 doctors attending
Thursday, December 18th 2025 - 3:30 PM (IST)
About this session
Dengue is currently the fastest-spreading mosquito-borne viral illness worldwide. Each year, an estimated 390 million infections occur, leading to roughly 500,000 hospitalizations and nearly 40,000 deaths. In 2023, the World Health Organization classified dengue as a Grade 3 emergency—the highest level—following a surge of outbreaks across multiple regions. India continues to shoulder a substantial share of the global burden, accounting for nearly one-third of all reported cases, with 233,519 infections and 297 deaths recorded in 2024.
While many dengue infections remain asymptomatic, the disease presents a broad clinical spectrum—from mild, unrecognized illness to severe, life-threatening complications. The progression to severe dengue is influenced by several factors, including age, prior dengue exposure, underlying health conditions, and the infecting viral serotype. Understanding these determinants is crucial for timely diagnosis, effective management, and improved outcomes.
Join us for this webinar as we explore the key drivers of dengue severity, identify high-risk groups, and discuss the complications.
Faculty
Key details
Registration
Free
Duration
60 min
Replay
Yes
Certificate
No
Language
English
Supported by
Explore other sessions
Disclaimer
This information is solely intended for the use of Registered Healthcare Practitioner / Registered Medical Practitioner only. The information contained herein is based on the published medical literature and international recommended guidelines. The information provided is intended for educational purposes only, aimed at increasing awareness on Dengue and not meant for promotion of any specific product. Registered Healthcare Practitioner / Registered Medical Practitioner shall apply their independent medical judgement for diagnosing or assessing or treating any patient. Takeda makes no representation or warranty concerning the information / content provided and assumes no responsibility for the accuracy of the of the information or content or opinion furnished or any outcome based on the application of such information. This material contains copyright protected information, content; the use of which is limited by law and this material cannot be reproduced, replicated, used or modified by any person for their own use or further distribution.
CONFIDENTIAL - FOR THE USE OF REGISTERED MEDICAL PRACTITIONER ONLY
TAKEDA and the TAKEDA logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited.
C-ANPROM/IN/NON/0027 Date of preparation: November, 2025